Labcorp
Labcorp, officially known as Laboratory Corporation of America Holdings, is a leading global life sciences company headquartered in the United States. Founded in 1971, Labcorp has established itself as a key player in the diagnostics and drug development sectors, with a strong presence across North America and Europe. The company offers a comprehensive range of laboratory services, including clinical laboratory testing, drug development, and genomic testing. Labcorp's commitment to innovation and quality sets it apart, providing healthcare professionals with critical insights to improve patient outcomes. Recognised for its extensive test menu and advanced technologies, Labcorp has achieved significant milestones, including the introduction of pioneering diagnostic solutions. With a robust market position, Labcorp continues to drive advancements in healthcare, making it a trusted partner for patients and providers alike.
DitchCarbon Score
How does Labcorp's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Labcorp's score of 38 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Labcorp's reported carbon emissions
In 2023, Labcorp reported total carbon emissions of approximately 331,967,000 kg CO2e, with significant contributions from Scope 1, Scope 2, and Scope 3 emissions. Specifically, Scope 1 emissions were about 182,265,000 kg CO2e, while Scope 2 emissions totalled approximately 149,702,000 kg CO2e. The company’s Scope 3 emissions were notably high, reaching around 1,050,378,000 kg CO2e, primarily from purchased goods and services, upstream transportation, and downstream distribution. Labcorp has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using 2020 as the baseline year. Additionally, the company targets a 25% reduction in absolute Scope 3 emissions from key categories, including purchased goods and services, as well as transportation and distribution activities, within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are designed to support global efforts to limit temperature rise to 1.5°C. Overall, Labcorp's emissions data and reduction targets reflect a proactive approach to addressing climate change, positioning the company as a responsible player in the pharmaceuticals and biotechnology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 173,797,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 175,982,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 909,611,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Labcorp is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
